BioSig Technologies, Inc (BSGM) - שווי החברה ברכישה מלאה

This Biosig Technologies (BSGM) price chart illustrates the company's valuation, which currently stands at . The firm is facing slow adoption of cardiac signal filters in clinics and a rapid cash burn. In response, the business is pivoting its strategic direction, seeking to monetize its intellectual assets and preserve liquidity. The operating model relies on outsourced electronics assembly in the US, ensuring high logistical mobility.

For Biosig Technologies (BSGM), which monetizes support for ECG filtration systems, the enterprise value reflects the actual cost of acquiring the company inclusive of its net liabilities. By analyzing the enterprise value metric, an investor sees the sum of market capitalization and debt minus cash, allowing for an assessment of the sustainability of the long-term equipment service model.